Introduction
As a tertiary care hospital, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM) General Hospital is mostly serving diabetic patients with multiple complications. Cancer prevalence in diabetic patients in Bangladesh seems to be increasing as case detection of both diseases are far more than before. No statistical data of diabetic patients with cancer is currently available in Bangladesh. Worldwide, cancer is the second and diabetes is the 12 th leading cause of death. 1 Taking care of diabetes and malignancy in the same patient is challenging. In Bangladesh where advanced treatment facilities are limited, a patient with cancer and uncontrolled diabetes often suffers. Sometimes cancer patients with uncontrolled diabetes are referred to our hospital before any intervention. Vice versa, when a patient with diabetes is detected with malignancy we refer the patient to cancer specialist/cancer hospitals.
To reduce the sufferings of the patients, especially those who require intensive diabetic care, we have started treating cases with cancers in Internal Medicine Department with limited resources and facilities. For such cases BIRDEM General Hospital also offers supportive facilities including intensive care, chemotherapy, surgical intervention and oncology day care.
Methods
In this cross-sectional, observational study from January 2012 to June 2016, cancer in adult patients irrespective of their diabetic status admitted in Internal Medicine Department of BIRDEM General Hospital were included. With prior informed consent of the patients data was collected and statistical analysis was done using professional SPSS version 17.0 windows based program.
Results
Total number of cancer patients was 114, whose diagnoses were confirmed by histopathological evidence (biopsy/FNAC), radiology reports and cancer markers. Among them 64 (56.1%) were male and 50 (43.9%) were female patients. Most (80, 70.2%) of the patients were diabetic. Among other co-morbid conditions (Table I) , hypertension (HTN) and ischemic heart disease (IHD) were predominant (17 and 9 cases respectively). Prevalence of more than one comorbidites were marked in the diabetic group (33 cases, p value >0.001). Twenty one categories of malignancies were diagnosed during this study period. Majority of cases were lymphoma (21,18.4%), carcinoma breast (17,14.9%), carcinoma uterus and/or cervix (13,11.4%) and leukaemia (10,8.8%). In the diabetic group increased prevalence of lymphoma and carcinoma breast were observed (Table III) . Common clinical features (Table IV) included palpable lump (21, 18.4%), lymphadenopathy (16, 14%), anaemia (9, 7.9%) and pain (8, 7%). The number of patients presenting with multiple signs/symptoms were also significant (32, 28.1%).
Case confirmation mostly was done by tissue diagnosis (histopathology) following biopsy (97, 76.3%) and FNAC (22, 19.3%). Other modalities included radioimaging, cancer markers etc (Table V) . On admission, in diabetic and non-diabetic groups mean haemoglobin was 9.7 and 9.9 gm/L respectively. Mean erythrocyte sedimentation rate (ESR) was 63.7 and 60.1 mm in 1 st hour in diabetic and non-diabetic group respectively. The few cases of oncologic emergencies were either admitted with it or later developed the emergency during admission (Table VI) . Among those, marrow failure (6, 5.3%), sepsis (5, 4.4%) and hypercalcaemia (4, 3.5%) were common. Our study was a small sample based study to share our experience in the field of oncology. Most of the patients were diabetic as this is a well-known diabetes treating institute. In this study majority suffered from lymphoma in both sexes (both Hodgkin and Non-Hodgkin lymphoma) while in adult female patients carcinoma breast, uterine and/or cervical carcinoma were common.
About 57% of study sample are within age limit of 41 to 60 years which correlates with Bangladesh Cancer Registry Report that showed maximum number of the cancer patients were in age group between 30-65 years, which is around 66% 3 . Most diabetic patients with complications were of older age. On the other hand a good portion of the non-diabetic group were hospital staffs who were detected early as a case of cancer as they were entitled to hospital facilities and also due to early referral.
Epidemiological findings have shown upto two-fold increases in the risks of cancers of the colorectum, breast, endometrium, kidney (renal cell tumours), liver and pancreas among diabetic patients 4 . In our study, carcinoma (breast, uterus and/or cervix, pancreas, rectum, prostate, renal, urinary bladder), lymphoma and multiple myeloma were found to be predominant in diabetic group (table VI) . Some risk factors are common to both cancer and diabetes which include age, sex, obesity, physical activity, diet, alcohol, and smoking 5 . So, addressing those risk factors may be of benefit in avoiding occurrence of some malignancies.
Majority of patients presented with different clinical features while asymptomatic cases with incidental cancer diagnosis is quite negligible in this study. Another study showed incidental rate is much higher, (e.g. in endometrial carcinoma) in diabetic patients 6 .
Case diagnosis was done largely based on tissue diagnosis (76.3%) from histopathology samples of bone marrow aspiration and organ biopsy. Many of the cases were suspected initially by radiological evidence which were later proved by histopathology, eventually a combine approach. Only in 2 cases secondary metastases were detected, the primary origins of which remain undiagnosed.
As most of the patients were admitted as routine cases or through emergency department with diabetes related complications, cases with oncological emergencies were less (only about 20%). Very few suffered from sepsis, marrow failure or tumerlysis syndrome as a direct consequence of chemotherapy or surgery. There was a significant difference among diabetic and non-diabetic group concerning the incidence of oncology emergency any time (21.25% and 17.6% respectively). This can be explained by concurrent co-mordities and/or complications occurring in diabetic group rather than the non-diabetic group. There are very few studies relating oncological emergency to diabetes. Study with common oncological emergencies in general population with cancer referred back to past 1994 7 .
Few cases (e.g. carcinoma breast) were referred out for radio/brachytherapy after complication of chemotherapy developed .Paliative care including surgery/stenting and chemotherapy were offered to few patients with multiple metastasis.
The combined data of 'cured' and 'patient with good response' is significant (54.4%). Non-diabetic group showed more positive response to treatment (61.76%). Even after active empathic care 14% patients condition deteriorated and 7% died. Such outcomes are expected in complicated diabetes with terminal illness 8 .
Conclusion
The terms 'cancer' as well as 'diabetes' is very wellknown in the general population of our country. Incidence of both the diseases are progressively increasing, affecting life physically, socially, financially and psychologically. People are now more cautious and availability of newer and better investigation tools are unveiling the asymptomatic cases in the community. When a diabetic patient develops malignancy, the situation gets complicated. This group of patients need proper control of their glycaemic profile and specific management of malignancy at the same time. Often multi-disciplinary management is required. BIRDEM General Hospital, as a tertiary institute has a promising role here. Our oncology unit started this journey with small steps looking forward to provide a better future to all patients who are fighting against cancer with or without diabetes mellitus.
